BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26405025)

  • 1. Posterior reversible encephalopathy syndrome in a patient with lupus nephritis on rituximab therapy: a challenge to find the offender.
    Mondal S; Goswami RP; Sinha D; Basu K; Das S; Ghosh P; Ghosh A
    Lupus; 2016 Apr; 25(4):445-6. PubMed ID: 26405025
    [No Abstract]   [Full Text] [Related]  

  • 2. Rituximab-associated posterior reversible encephalopathy syndrome.
    Mustafa KN; Qasem U; Al-Ryalat NT; Bsisu IK
    Int J Rheum Dis; 2019 Jan; 22(1):160-165. PubMed ID: 30398015
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of PRES in an active lupus nephritis patient after treatment of corticosteroid and cyclophosphamide.
    Jabrane M; Ait Lahcen Z; Fadili W; Laouad I
    Rheumatol Int; 2015 May; 35(5):935-8. PubMed ID: 25387825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients.
    Zekić T; Benić MS; Antulov R; Antončić I; Novak S
    Rheumatol Int; 2017 Dec; 37(12):2105-2114. PubMed ID: 29043491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posterior reversible encephalopathy syndrome in SLE nephritis.
    Sinha R; Hurley RM
    Postgrad Med J; 2008 Jan; 84(987):56. PubMed ID: 18230753
    [No Abstract]   [Full Text] [Related]  

  • 6. Tacrolimus-Associated Posterior Reversible Encephalopathy Syndrome in Renal Transplant Recipient in Early Posttransplant Period: Case Report.
    Hassan SMA
    Exp Clin Transplant; 2024 Jan; 22(Suppl 1):336-337. PubMed ID: 38385421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate-Induced Posterior Reversible Encephalopathy Syndrome.
    Khajuria B; Khajuria M; Agrawal Y
    Am J Ther; 2016; 23(4):e1072-3. PubMed ID: 25933141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus following methylprednisolone: report of two cases.
    Chennareddy S; Adapa R; Kishore BK; Rajasekhar L
    Int J Rheum Dis; 2013 Dec; 16(6):786-8. PubMed ID: 24131800
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversible posterior leukoencephalopathy syndrome after rituximab.
    Zito JA; Lee CC; Johnson S; Singer A; Vacirca J
    Am J Emerg Med; 2010 May; 28(4):537.e1-2. PubMed ID: 20466257
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversible posterior encephalopathy syndrome in systemic lupus erythematosus and lupus nephritis.
    Zhang YX; Liu JR; Ding MP; Huang J; Zhang M; Jansen O; Deuschl G; Eschenfelder CC
    Intern Med; 2008; 47(9):867-75. PubMed ID: 18451582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed Diagnosis of Posterior Reversible Encephalopathy Syndrome: A Case Report.
    Pegany R; Olson DJ; Aldaas KM; Sitko KR
    J Neuroophthalmol; 2021 Mar; 41(1):e64-e65. PubMed ID: 32355047
    [No Abstract]   [Full Text] [Related]  

  • 12. Posterior reversible encephalopathy syndrome in a patient with lupus nephritis.
    Kadikoy H; Haque W; Hoang V; Maliakkal J; Nisbet J; Abdellatif A
    Saudi J Kidney Dis Transpl; 2012 May; 23(3):572-6. PubMed ID: 22569448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early onset neutropenia and thrombocytopenia following rituximab in lupus nephritis.
    Shah S; Kavadichanda CG; Belani P; Ganesh RN; Negi VS
    Int J Rheum Dis; 2019 May; 22(5):946-950. PubMed ID: 30168270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterior reversible encephalopathy syndrome masquerading as progressive multifocal leukoencephalopathy in rituximab treated neuromyelitis optica.
    Berger JR; Neltner J; Smith C; Cambi F
    Mult Scler Relat Disord; 2014 Nov; 3(6):728-31. PubMed ID: 25891552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posterior reversible encephalopathy syndrome in a patient with mixed connective tissue disease: a case report.
    Rahmanzadeh R; Rahmanzade R; Zabihiyeganeh M
    J Med Case Rep; 2016 Jun; 10(1):145. PubMed ID: 27250498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Case of posterior reversible encephalopathy syndrome due to azathioprine].
    Ogawa R; Oikawa T; Shijo T; Kanno S; Shibuya S; Mochizuki H
    Rinsho Shinkeigaku; 2015; 55(12):936-9. PubMed ID: 26511023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated leptomeningeal enhancement in tacrolimus-associated posterior reversible encephalopathy syndrome.
    Fitzgerald RT; Osorio J; Panigrahy A; Mazariegos GV; Zuccoli G
    Pediatr Neurol; 2013 Jan; 48(1):76-8. PubMed ID: 23290027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posterior reversible encephalopathy syndrome in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome.
    Jung SM; Moon SJ; Kwok SK; Ju JH; Park KS; Park SH; Kim HY
    Lupus; 2013 Aug; 22(9):885-91. PubMed ID: 23846231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithymocyte globulin induced posterior reversible encephalopathy in aplastic anemia.
    Dayama A; Seth T; Mishra P; Mahapatra M
    Neurol India; 2013; 61(4):430-1. PubMed ID: 24005743
    [No Abstract]   [Full Text] [Related]  

  • 20. Irreversible Lesions of Tacrolimus-induced Posterior Reversible Leukoencephalopathy Syndrome.
    Savaj S; Farasatinasab M; Amouzegar A
    Iran J Kidney Dis; 2017 Nov; 11(6):408. PubMed ID: 29190599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.